Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia

NCT02700048 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped research grant for the trial was not funded

Conditions

Hypoglycemia Unawareness
Type 1 Diabetes

Interventions

DRUG: intra-nasal naloxone
DRUG: Intra-nasal saline

Sponsor

University of Minnesota